MDM2 binds and inhibits vitamin D receptor

Area of Science:

• Molecular Biology
• Cancer Biology
• Biochemistry

Background:

• MDM2 is a known inhibitor of p53 tumor suppressors.
• Vitamin D Receptor (VDR) is a transcriptional regulator and potential tumor suppressor.

Purpose of the Study:

• To investigate the interaction between MDM2 and VDR.
• To determine if MDM2 affects VDR stability and transcriptional activity.

Main Methods:

• Co-immunoprecipitation to detect VDR-MDM2 binding.
• Western blotting to assess VDR protein levels.
• Luciferase reporter assays to measure VDR transactivation.
• Gene silencing (knockdown) of MDM2.

Main Results:

• MDM2 binds to VDR, inhibiting its function independently of vitamin D ligand.
• MDM2 promotes VDR ubiquitylation and proteasomal degradation, controlling its steady-state level.
• MDM2 suppresses VDR-mediated transactivation of target genes like CYP24A1 and p21.

Conclusions:

• MDM2 negatively regulates VDR stability and transcriptional activity.
• This regulation occurs through ubiquitylation and proteasomal degradation, and direct inhibition of transactivation.
• MDM2's interaction with VDR parallels its known inhibitory role on p53.